Blood collection in Brazil is entering a new era of modernization. The National Health Surveillance Agency (Anvisa) has approved the Tasso device, an innovative technology designed to collect small capillary blood samples in a minimally invasive way, eliminating the need for traditional needles.
With this authorization, Brazil becomes one of the first countries in Latin America to adopt this type of solution. The Tasso device operates quickly and simply: users apply it directly to the skin, usually on the arm or another recommended area, and its precise mechanism collects the required amount of blood.
A Faster and More Comfortable Alternative to Traditional Blood Collection
The procedure causes almost no pain and takes only a few minutes to complete, giving children, older adults, people with needle phobia (trypanophobia), and patients who need frequent blood tests a more comfortable option.
Beyond improving the patient experience, the technology can also benefit the healthcare system by reducing the need for conventional blood draws and lowering risks associated with venipuncture, including bruising, infections, and accidental needle injuries.
Its convenience may encourage more people to undergo regular health screenings, which are essential for the early detection and follow-up of conditions such as diabetes, anemia, thyroid disorders, and cancer therapies.
Expanding Access to Screening and Digital Healthcare Solutions
Researchers and healthcare professionals also highlight its potential to strengthen public health initiatives by making screening programs, disease surveillance, and telemedicine services more accessible. The technology integrates into existing healthcare workflows because laboratories can analyze Tasso-collected samples using standard testing methods.
The introduction of Tasso in Brazil reflects a global movement toward more patient-friendly and innovative diagnostic methods. Anvisa has already approved the device, and laboratories, clinics, and healthcare facilities are expected to introduce it gradually, making blood collection more efficient, accessible, and comfortable.
The approval represents another step toward healthcare solutions that prioritize patient comfort, safety, and quality of care.
Read the original article on:msconecta
Read more:OpenAI introduces Codex Micro, its latest AI coding hardware